CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway. Ji J, Shen T, Li Y, Liu Y, et al. Oncol Rep 2021;45:921-932.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ji J, Shen T, Li Y, Liu Y, et al. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway. Oncol Rep 2021;45:921-932.
PMID: 33650660